Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2018 06:00 ET | Source: Arvinas Inc.

Arvinas To Present at the 30th Annual Piper Jaffray Healthcare Conference

NEW HAVEN, Conn., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on protein degradation, today announced that John G....
October 23, 2018 07:30 ET | Source: Arvinas Inc.

Arvinas to Present at Two Protein Degradation Conferences

NEW HAVEN, Conn., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on protein degradation, today announced it will be...
September 26, 2018 20:06 ET | Source: Arvinas Inc.

Arvinas Announces Pricing of Initial Public Offering

NEW HAVEN, Conn., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and...